A Review of Neuro-Ophthalmological Manifestations of Human Coronavirus Infection

References

• Masters PS. The molecular biology of coronaviruses. Adv Virus Res. 2006;65(06):193–292. doi:doi:10.1016/S0065-3527(06)66005-3
   Web of Science ®Google Scholar
• Siddell SG, Anderson R, Cavanagh D, et al. Coronaviridae. Intervirology. 1983;20:181–189. doi:10.1159/0001493906654644
   PubMed Web of Science ®Google Scholar
• Virus Taxonomy: 2019 Release. ICTV (International Committee on Taxonomy of Viruses). Available from: https://talk.ictvonline.org/ictv-reports/ictv_9th_report/positive-sense-rna-viruses-2011/w/posrna_viruses/222/coronaviridae.
   Google Scholar
• Decaro N, Lorusso A. Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses. Vet Microbiol. 2020;244(April):108693. doi:doi:10.1016/j.vetmic.2020.10869332402329
   PubMed Web of Science ®Google Scholar
• Gorbalenya AE, Baker SC, Baric RS, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–544. doi:doi:10.1038/s41564-020-0695-z32123347
   PubMed Web of Science ®Google Scholar
• WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https://covid19.who.int/.
   Google Scholar
• Gharebaghi R, Desuatels J, Moshirfar M, Parvizi M, Daryabari SH, Heidary F. Covid-19: preliminary clinical guidelines for ophthalmology practices. Med Hypothesis, Discov Innov Ophthalmol. 2020;9(2):149–158.32490022
   PubMedGoogle Scholar
• Desforges M, Le Coupanec A, Dubeau P, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12(1):1–28. doi:doi:10.3390/v12010014
   Web of Science ®Google Scholar
• Desforges M, Le Coupanec A, Stodola JK, Meessen-Pinard M, Talbot PJ. Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res. 2014;194:145–158. doi:doi:10.1016/j.virusres.2014.09.01125281913
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637. doi:doi:10.1002/path.157015141377
   PubMed Web of Science ®Google Scholar
• Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552–555. doi:doi:10.1002/jmv.2572832104915
   PubMed Web of Science ®Google Scholar
• Heidary F, Varnaseri M, Gharebaghi R. The potential use of persian herbal medicines against COVID-19 through angiotensin-converting enzyme 2. Arch Clin Infect Dis. 2020 Online ahead of Print; 15(COVID–19):e102838. doi:doi:10.1136/bmj.m810
   Web of Science ®Google Scholar
• Holappa M, Vapaatalo H, Vaajanen A. Many faces of renin-angiotensin system - focus on eye. Open Ophthalmol J. 2017;11(1):122–142. doi:doi:10.2174/187436410171101012228761566
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:7. doi:doi:10.1371/journal.pmed.1000097
   Web of Science ®Google Scholar
• Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;2019:4–7. doi:doi:10.1001/jamaophthalmol.2020.1291
   Web of Science ®Google Scholar
• Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 Patients. Ophthalmology. 2020. doi:doi:10.1016/j.ophtha.2020.04.028
   Google Scholar
• Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS‐CoV‐2 in patients confirmed with COVID‐19. Acta Ophthalmol. 2020;1–7. doi:doi:10.1111/aos.1444532749776
   PubMed Web of Science ®Google Scholar
• Navel V, Chiambaretta F, Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am J Ophthalmol Case Reports. 2020;19(May):100735. doi:doi:10.1016/j.ajoc.2020.100735
   Google Scholar
• Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection. J Med Virol. 2020;92(6):589–594. doi:doi:10.1002/jmv.2572532100876
   PubMed Web of Science ®Google Scholar
• Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;figure 2:1–4. doi:doi:10.1136/bjophthalmol-2020-316304
   Web of Science ®Google Scholar
• Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019. Can J Ophthalmol Can D’ophtalmologie. 2020;2019:1–5. doi:doi:10.1016/j.jcjo.2020.03.003
   Web of Science ®Google Scholar
• Loon SC, Teoh SCB, Oon LLE, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004;88(7):861–863. doi10.1136/bjo.2003.03593115205225
   PubMed Web of Science ®Google Scholar
• Van Der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368–373. doi:doi:10.1038/nm102415034574
   PubMed Web of Science ®Google Scholar
• Daruich A, Martin D, Bremond-Gignac D. Ocular manifestation as first sign of coronavirus disease 2019 (COVID-19): interest of telemedicine during the pandemic context. J Fr Ophtalmol. 2020;43:389–391. doi:10.1016/j.jfo.2020.04.00232334847
   PubMed Web of Science ®Google Scholar
• Pei X, Jiao X, Lu D, Qi D, Huang S, Li Z. How to face COVID-19 in ophthalmology practice. Med Hypothesis Discov Innov Ophthalmol. 2020;9(3):164–171.
   Google Scholar
• SirakayaE, SahinerM, Sirakaya HAA.A Patient with bilateral conjunctivitis positive for Sars-Cov-2 RNA in conjunctival sample.Cornea.2020 Jul 2:10.1097/ICO.0000000000002485.doi:10.1097/ICO.0000000000002485.Epub ahead of print
   Web of Science ®Google Scholar
• Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? a review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:10.1080/09273948.2020.173850132175797
   PubMed Web of Science ®Google Scholar
• Marinho PM, Marcos AAA, Romano AC, Nascimento H. Retinal findings in patients with COVID-19. Lancet. 2020;395:1610. doi:10.1016/S0140-6736(20)31014-X32405105
   PubMed Web of Science ®Google Scholar
• Li Y, Li H, Fan R, et al. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology. 2017;59(3):163–169. doi:doi:10.1159/000453066
   Web of Science ®Google Scholar
• Yeh EA, Collins A, Cohen ME, Duffner PK, Faden H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics. 2004;113(1):e73–e76. doi:10.1542/peds.113.1.e7314702500
   PubMed Web of Science ®Google Scholar
• Murray RS, Brown B, Brain D, Cabirac GF. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol. 1992;31(5):525–533. doi:doi:10.1002/ana.4103105111596089
   PubMed Web of Science ®Google Scholar
• Stewart JN, Mounir S, Talbot PJ. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology. 1992;191(1):502–505. doi:doi:10.1016/0042-6822(92)90220-J1413524
   PubMed Web of Science ®Google Scholar
• Wege H, Schluesener H, Meyermann R, Barac-Latas V, Suchanek G, Lassmann H. Coronavirus infection and demyelination: development of inflammatory lesions in Lewis rats. Adv Exp Med Biol. 1998;440:437–444.9782312
   PubMed Web of Science ®Google Scholar
• Murray RS, MacMillan B, Cabirac G, Burks JS. Detection of Coronavirus RNA in CNS tissue of multiple sclerosis and control patients. Coronaviruses and their Diseases. Advances in Experimental Medicine and Biology 1990;276:505–510. doi:doi:10.1007/978-1-4684-5823-7_70
   Google Scholar
• Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74(19):8913–8921. doi:doi:10.1128/JVI.74.19.8913-8921.200010982334
   PubMed Web of Science ®Google Scholar
• Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci. 2020;413:116832. doi:doi:10.1016/j.jns.2020.11683232299017
   PubMed Web of Science ®Google Scholar
• Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020. doi:doi:10.1001/jamaneurol.2020.1127
   Web of Science ®Google Scholar
• Werner C, Scullen T, Mathkour M, et al. Neurological impact of coronavirus disease (COVID-19): practical considerations for the neuroscience community. World Neurosurg. 2020. doi:doi:10.1016/j.wneu.2020.04.222
   Web of Science ®Google Scholar
• Goldberg MF, Goldberg MF. Cerebrovascular DIsease in COVID-19. American Journal of Neuroradiology. 2020;41(7).
   Google Scholar
• Brouwer MC, Ascione T, Pagliano P. Neurologic aspects of COVID-19: A concise Review. Infez Med. 2020;28:42–45.32532937
   PubMedGoogle Scholar
• Saxena R, Singh D, Jethani J, et al. Pediatric ophthalmology, strabismus and neuro-ophthalmology practice in the COVID-19 era: all India Ophthalmological Society guidelines. Indian J Ophthalmol. 2020;68(7):1300–1305. doi:doi:10.4103/ijo.IJO_1789_2032587154
   PubMed Web of Science ®Google Scholar
• Cariddi LP, Damavandi PT, Carimati F, et al. Reversible Encephalopathy Syndrome (PRES) in a COVID ‑ 19 patient. J Neurol. 2020;0123456789:5–8. doi:doi:10.1007/s00415-020-10001-7
   Web of Science ®Google Scholar
• Hanafi R, Roger P-A, Perin B, et al. COVID-19 neurologic complication with CNS vasculitis-like pattern. AJNR Am J Neuroradiol. 2020;1–4.31924602
   PubMed Web of Science ®Google Scholar
• Sotoca J, Rodríguez-Álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflam. 2020;7:e803. doi:doi:10.1212/NXI.0000000000000803
   PubMed Web of Science ®Google Scholar
• Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020. doi:doi:10.1212/WNL.0000000000009700
   Web of Science ®Google Scholar
• Juliao Caamaño DS, Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain-Barré syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. 2020. doi:doi:10.1016/j.jocn.2020.05.016
   Web of Science ®Google Scholar
• Hutchins KL, Jansen JH, Comer AD, Scheer RV. COVID-19 – associated bifacial weakness with paresthesia subtype of Guillain-Barré syndrome. AJNR Am J Neuroradiol. 2020;1–5.31924602
   PubMed Web of Science ®Google Scholar
• Webb S, Wallace VCJ, Martin- D, Yogarajah M. Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication. BMJ Case Rep. 2020;3:e236182. doi:doi:10.1136/bcr-2020-236182
   Google Scholar
• Riva N, Russo T, Falzone YM, et al. Post‑infectious Guillain–Barré syndrome related to SARS‑CoV‑2 infection: a case report. J Neurol. 2020. doi:doi:10.1007/s00415-020-09907-z
   Web of Science ®Google Scholar
• Li Z, Liu T, Yang N, et al. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med. 2020. doi:doi:10.1007/s11684-020-0786-5
   Web of Science ®Google Scholar
• Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol. 2017;13(3):227–233. doi:doi:10.3988/jcn.2017.13.3.22728748673
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. doi:doi:10.1016/S0140-6736(20)30183-5
   Web of Science ®Google Scholar
• Li R, Tian J, Yang F, et al. Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China. J Clin Virol. 2020;127(April):1–3. doi:doi:10.1016/j.jcv.2020.104363
   Web of Science ®Google Scholar
• Zheng Y, Xiong C, Liu Y, et al. Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020. Pharmacol Res. 2020:104821. doi:10.1016/j.phrs.2020.104821.32360481
   PubMed Web of Science ®Google Scholar
• Tostmann A, Bradley J, Bousema T, et al. Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020. Eurosurveillance. 2020;25:16. doi:doi:10.2807/1560-7917.es.2020.25.16.2000508
   Web of Science ®Google Scholar
• Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020. doi:doi:10.1212/wnl.0000000000009619
   Web of Science ®Google Scholar
• Pellitero SE, Ferrer-Bergua LG. Paciente Con Clínica Neurológica Como Única Manifestación De Infección Por Sars-Cov-2. Neurología. 2020. doi:doi:10.1016/j.nrl.2020.04.010
   Web of Science ®Google Scholar
• Xiang P, Xu X, Gao L, Wang H, Xiong H, Li R. First case of 2019 novel coronavirus disease with encephalitis. ChinaXiv. 2020.
   Google Scholar
• Bolay H, Gul A, Baykan B. COVID-19 is a real headache! 2020. doi:doi:10.1111/head.13856
   Google Scholar
• Zhu J. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis Clinical characteristics of COVID-19: a meta-analysis. J Med Virol. 2020. doi:10.1002/jmv.25884
   Google Scholar
• Bigaut K, Mallaret M, Baloglu S, et al. Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflam. 2020;(7):e785. doi:doi:10.1212/NXI.0000000000000785
   Web of Science ®Google Scholar
• Toscano G, Palmerini F, Ravaglia S, et al. Guillain–barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020. doi:doi:10.1056/NEJMc2009191
   Web of Science ®Google Scholar
• Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Syst. 2020. doi:doi:10.1111/jns.12382
   Web of Science ®Google Scholar
• Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383–384. doi:doi:10.1016/S1474-4422(20)30109-532246917
   PubMed Web of Science ®Google Scholar
• Marta-Enguita J, Rubio-Baines I, Gastón-Zubimendi I. Síndrome de Guillain-Barré fatal tras infección por el virus SARS-CoV-2. Neurología. 2020. doi:doi:10.1016/j.nrl.2020.04.004
   Web of Science ®Google Scholar
• Sedaghat Z, Karimi N. Guillain-Barre syndrome associated with COVID-19 infection: A case report. J Clin Neurosci. 2020. doi:doi:10.1016/j.jocn.2020.04.062
   Web of Science ®Google Scholar
• Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020:1–8. doi:10.1016/S0140-6736(20)31103-X.
   Web of Science ®Google Scholar